Document Detail


Electroconvulsive therapy: a review on indications, methods, risks and medication.
MedLine Citation:
PMID:  19698445     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
This paper reviews and presents data of practical impact for those administering electroconvulsive therapy (ECT). In the first section, physical and physiological aspects of the stimulus as well as methods of stimulation are discussed. The second section deals with indications for ECT, efficacy and treatment modalities such as seizure duration, treatment frequency and total number of ECT applications. The last section is devoted to side effects, risks, comedication and comorbidity.
Authors:
A Stevens; A Fischer; M Bartels; G Buchkremer
Related Documents :
7796215 - Maintenance electroconvulsive therapy for chronic mentally ill patients: a case series.
24914395 - Ehealth monitoring in irritable bowel syndrome patients treated with low fermentable ol...
3855705 - Adriamycin and cytosine arabinoside contribute equally to prediction of response in acu...
19900715 - Persistent nightmares are associated with repeat suicide attempt: a prospective study.
24428135 - Outcome evaluation of the opioid agonist maintenance treatment in iran.
1484175 - The acute and long-term treatment of major depression.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European psychiatry : the journal of the Association of European Psychiatrists     Volume:  11     ISSN:  0924-9338     ISO Abbreviation:  Eur. Psychiatry     Publication Date:  1996  
Date Detail:
Created Date:  2009-08-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9111820     Medline TA:  Eur Psychiatry     Country:  France    
Other Details:
Languages:  eng     Pagination:  165-74     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cost-utility in CNS drug trials.
Next Document:  Functional hemisphere imbalance in patients with paranoid or disorganized schizophrenia.